TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma

Clinical trial NCT03506802 · WITHDRAWN

Trial details

NCT number: NCT03506802
Sponsor: Jonsson Comprehensive Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

HLA-A*0201 Positive Cells Present NY-ESO-1 Positive Tumor Cells Present Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2018-07-10
Primary completion: 2019-06-25
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.